Dr Horton (DHI) Stock
Major US homebuilder with scale and broad national presence. Here's the price, business snapshot, and what's worth knowing about Dr Horton in September 2026.
DR Horton, Inc. (DHI) is one of the largest US homebuilders, specialising in single‑family and select multi‑family housing across a broad range of price points. The company acquires land, builds homes and often provides related services such as mortgage lending and title insurance, which can add to margins. Revenue and profitability tend to track the housing cycle: demand, mortgage rates, and supply of existing homes are key drivers. DR Horton benefits from scale, a diversified national footprint and a large land inventory, but it is sensitive to interest‑rate rises, construction costs, labour availability and regional economic shifts. For investors, the company offers exposure to residential construction and the broader housing market, yet returns can be volatile and are not guaranteed. This summary is educational only and not personalised investment advice; investors should consider their goals, risk tolerance and seek professional guidance before acting.
Why It’s Moving
D.R. Horton is moving on a solid earnings beat, but a cautious outlook is keeping housing-market worries in focus.
- The latest catalyst is D.R. Horton’s fiscal Q3 results, where earnings and revenue both came in ahead of expectations, signaling that demand and pricing held up better than feared despite a softer housing backdrop.
- Even with the beat, investors are focusing on the company’s more cautious forward outlook, which suggests homebuilders still face pressure from affordability, mortgage-rate sensitivity, and a slower new-home market.
- Analyst sentiment remains tilted constructive, but the stock has been moving on the tension between near-term execution and the market’s concern that housing demand may not reaccelerate quickly.
D.R. Horton is moving on a solid earnings beat, but a cautious outlook is keeping housing-market worries in focus.
- The latest catalyst is D.R. Horton’s fiscal Q3 results, where earnings and revenue both came in ahead of expectations, signaling that demand and pricing held up better than feared despite a softer housing backdrop.
- Even with the beat, investors are focusing on the company’s more cautious forward outlook, which suggests homebuilders still face pressure from affordability, mortgage-rate sensitivity, and a slower new-home market.
- Analyst sentiment remains tilted constructive, but the stock has been moving on the tension between near-term execution and the market’s concern that housing demand may not reaccelerate quickly.
About This Stock
DR HORTON INC
DHI
Current Price
$137.93
Potential 12 Month Profit
13.54%
Sector
Consumer Cyclicals
Industry
Homebuilding & Construction Supplies
Ticker
DHI
Market Cap
$38.57B
Potential 12 Month Profit
13.54%
Sector
Consumer Cyclicals
Industry
Homebuilding & Construction Supplies
Sixth Month Growth Performance
When is the next earnings date for DR HORTON INC (DHI)?
D.R. Horton’s next earnings date is expected on October 29, 2026. It will cover fiscal fourth-quarter 2026 results. The company has also historically reported around this late-October window, so that date is consistent with its normal pattern.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying DR Horton’s stock with a target price of $161.64, indicating potential growth.
Financial Health
DR Horton is performing well with solid profits, cash flow, and revenue, indicating strong business operations.
Dividend
DR HORTON INC's dividend yield of 1.27% is low, indicating limited income potential for investors. If you invested $1000, you would be paid $12.70 a year in dividends (based on the last 12 months).
Why You’ll Want to Watch This Stock
Housing cycle exposure
DR Horton’s performance often mirrors housing demand and mortgage rates; it can benefit from strong markets but may see volatility when conditions cool.
Scale and footprint
A national presence and large land holdings can provide resilience and flexibility, though regional downturns and inventory risks remain.
Cost and rate pressures
Construction costs and interest‑rate moves directly affect margins and buyer affordability, so monitor these factors alongside sales trends.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
